Coherus Oncology Inc (CHRS)

Operating Expenses

$188.97M

TTM · Period ending: · USD

CHRS logo

CHRS Operating Expenses

Latest reported$188.97M
CHRS TTM Operating Expenses ($20.47M → $188.97M)
High-resolution chart · PNG

CHRS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
188,966,000
197,899,000
203,468,000
212,313,000
219,616,000
224,220,000
243,541,000
256,871,000
274,322,000
286,800,000
301,451,000
308,232,000
325,000,000
349,476,000
397,839,000
416,010,000
419,381,000
421,605,000
532,818,000
514,325,000
491,150,000
456,264,000
281,838,000
270,535,000
253,096,000
248,210,000
231,225,000
220,709,000
224,285,000
213,856,000
204,416,000
190,380,000
190,023,000
203,146,000
233,692,000
261,530,000
283,133,000
301,904,000
306,037,000
294,138,000
294,304,000
283,261,000
249,108,000
219,756,000
163,847,000
120,989,000
95,788,000
74,454,000
59,268,000
37,114,000
20,469,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.